Plasma Tissue Factor Plus Activated Peripheral Mononuclear Cells Activate Factors VII and X in Cardiac Surgical Wounds

• Published in: Journal of the American College of Cardiology 2005-08, Vol.46 (4), p.707-713
• Main Authors: Hattori, Takashi, Khan, Mohammad M.H., Colman, Robert W., Edmunds, L. Henry
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Biological and medical sciences; Blood Coagulation - physiology; Blood Coagulation Factors - physiology; Blood platelets; Blotting, Western; Cardiology; Cardiology. Vascular system; Cardiopulmonary Bypass - adverse effects; Enzymes; Factor VII - analysis; Factor VII - biosynthesis; Factor X - analysis; Factor X - biosynthesis; Female; Heart surgery; Humans; Injuries of the thorax. Foreign bodies. Diseases due to physical agents; Male; Medical sciences; Middle Aged; Monocytes - physiology; Plasma; Plasma - chemistry; Postoperative Care; Postoperative Hemorrhage - physiopathology; Proteins; Thrombin - biosynthesis; Thromboplastin - analysis; Traumas. Diseases due to physical agents; Wound Healing
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2005.05.040

The purpose of this study was to test the hypothesis that activated monocytes with soluble plasma tissue factor (pTF) activate factors VII and X to generate thrombin. Despite heparin, thrombin is progressively generated during cardiac surgery with cardiopulmonary bypass (CPB), produces intravascular fibrin and fibrinolysis, and causes serious thromboembolic and nonsurgical bleeding complications. Thrombin is primarily produced in the surgical wound, but mechanisms are unclear. In 13 patients, interactions of mononuclear cells, platelets, pTF, and pTF fractions to activate factors VII and X were evaluated in pre-bypass, perfusate, and pericardial wound blood before and during CPB. Monocytes are activated in wound, but not in pre-bypass or perfusate plasma (monocyte chemotactic protein-1 = 29.5 ± 2.1 pmoles/l vs. 2.8 ± 1.2 pmoles/l and 3.3 ±1.4 pmoles/l, respectively). Wound pTF is substantially elevated compared to other locations (3.64 ± 0.45 pmoles/l vs. 0.71 ± 0.65 pmoles/l and 1.31 ± 1.4 pmoles/l). Supernatant wound pTF contains 81.7% of TF antigen; wound microparticle pTF contains 18.3%. Wound monocytes and all C5a-stimulated monocytes (but not activated platelets) completely convert factor VII to factor VIIa with wound pTF. Activated monocytes more efficiently activate factor X with wound supernatant TF/factor VII(VIIa) complex than with wound microparticle TF/factor VII(fVIIa). The correlation coefficient (r) between wound thrombin generation (F1.2) and wound pTF concentration is 0.944 (p = 0.0004). During cardiac surgery with CPB, wound monocytes plus wound pTF or wound microparticle-free supernatant pTF preferentially accelerate activation of factor VII and factor X. This system represents a novel mechanism for thrombin generation via the TF coagulation pathway.